Riskpilot← Back to searchSign inGet full accessElsings Djurklinik AB
ABActiveOrg 5569370439Torphagebacken 1Veterinary activities · NACE 7500Est. 201310-19 employees
Revenue 2025
SEK 50,9M
+9% vs 2024
EBITDA margin
42.3%
-20% vs 2024
Equity ratio
62.1%
Financial strength
Net profit 2025
SEK 8,5M
-45% vs 2024
| Revenue | SEK 50,9M | +9% |
| EBITDA | SEK 21,5M | -20% |
| Net profit | SEK 8,5M | -45% |
| Total assets | SEK 67,8M | +11% |
| Equity | SEK 42,1M | -4% |
| Employees | — | — |
Legal name
Elsings Djurklinik AB
Org number
5569370439
Legal form
Aktiebolag
NACE code
7500 · Veterinary activities
Founded
9 juli 2013
Share capital
SEK 50 000
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva djursjukvård samt därmed förenlig verksamhet.
Address
Torphagebacken 1
Phone
+46731569156
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 27 909 | 31 958 | 37 377 | 46 930 | 50 931 |
| Staff expenses | — | — | — | −7 296 | — |
| EBITDA | 12 360 | 12 396 | 18 330 | 26 891 | 21 549 |
| Depreciation & amort. | −1 570 | −1 739 | −2 130 | −2 107 | −2 179 |
| EBIT | 10 790 | 10 657 | 16 200 | 24 785 | 19 370 |
| Net financials | −44 | −164 | 351 | 1 370 | 241 |
| Profit before tax | 10 528 | 11 187 | 12 344 | 19 370 | 12 701 |
| Tax | −2 261 | −2 322 | −2 566 | −4 054 | −4 209 |
| Net profit | 8 267 | 8 865 | 9 778 | 15 317 | 8 492 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 45 431 | 52 040 | 52 148 | 61 006 | 67 848 |
| Equity | 28 888 | 36 753 | 35 532 | 43 848 | 42 143 |
| Long-term debt | 10 827 | 10 507 | 0 | — | 0 |
| Short-term debt | 3 158 | 2 677 | 10 067 | 5 524 | 7 163 |
| Total debt | 13 985 | 13 184 | 10 067 | 5 524 | 7 163 |
EBITDA margin
42.3%
This company
15.8%
Market median
+168% vs market
20212025
Equity ratio
62.1%
This company
38.2%
Market median
+63% vs market
20212025
Return on equity
20.2%
This company
18.4%
Market median
+10% vs market
20212025
Net profit margin
16.7%
This company
8.1%
Market median
+106% vs market
20212025
Asset turnover
0.75×
This company
1.12×
Market median
-33% vs market
20212025
Debt / equity
0.61×
This company
0.62×
Market median
+2% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KW Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Elsing Enter Group AB
Elsings Djurklinik AB Board members of Elsings Djurklinik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl William Ekenfall | Chief Auditor | 0 companies |
| Lars Elsing | Deputy Board Member | 0 companies |
| Gustaf Elsing Elsing | Board of Directors | 0 companies |